A marketer who is not a developer built a local-language AI calorie tracker with Cursor that he says makes over $80K a month
Tomer brought the CalAI idea to the Israeli market in Hebrew and grew it with paid ads where ad prices are lower.
Subject: Tomer (AI calorie tracker app)Subscription mobile app localized for one country
Case Overview & Background
Tomer came from marketing and had only a little coding experience. He saw that a popular AI calorie tracking app did not exist in his local language, so he built one for that market. Like CalAI, the user takes a picture of a meal and gets calories and macros in seconds, but the app is in Hebrew and adjusted for local users.
How AI Is Used
Step-by-Step Process
He chose a popular US app idea that had no local version.
He had a working version after two weeks with Cursor.
He found paid ads profitable because local ad prices are lower than in the US.
Customer Acquisition & Distribution
Limitations, Risks & Failure Modes
What may not apply to you, and what could go wrong:
- The figures are self-reported and were not independently checked
- Large global apps can add local language support
- Paid ads tie growth to ad costs
Key Takeaways
- Localizing a proven AI app can be a fast route to revenue
- Marketing skill can matter more than coding skill when AI writes the code
Sources
Starter Story: I Copied A Huge App. Now I Make $80K/Month
Note: Video interview with transcript. States the over 80k per month figure, the Cursor build and the paid ads strategy.
Category page banner: Reach readers researching one specific AI business model.
One clearly labelled banner on a category page such as Micro-SaaS or AI Agencies, shown next to the documented cases your product is relevant to.
Sponsored placements are always labelled and never change how cases are researched, labelled, or ranked.
Commercial disclosure: We currently have no affiliate or sponsorship relationship with any tool or person on this page. If that changes, affiliate links and sponsored content will be clearly labelled, and evidence labels will never be changed for commercial reasons.
